James Rowe
Tel.
Position
Visiting Professor
Affiliations
University of Copenhagen and University of Cambridge
Personal webpage
Research Interests
I work for the better understanding, diagnosis and treatment of degenerative brain diseases, including dementia and parkinsonian disorders. With my UK based group, we bring together computational models of brain and behaviour, physiology (MEG), structural and functional brain imaging (3T and 7T), and biomarkers of pathology (PET/blood), genetics and experimental treatments. I am here on sabbatical, having enjoyed working at DRCMR before, in 2004 and 2019.
Research Groups
Advanced Brain Imaging of Neurological and Psychiatric Disorders
Motor Control and Cognitive Neuroscience
Curriculum Vitae
Education
2012
FRCP, London
2005
CCT Neurology
2001
PhD in Neuroscience, UCL
1997
MRCP
1994
BM BCh in Medicine, University of Oxford
1991
BSc in Experimental Psychology, University of Cambridge
Employments
2020 - Present
Associate Director, Dementia Platform UK
2020 - Present
Chief Scientific Advisor, Alzheimer Research UK
2015 - Present
Professor of Cognitive Neurology, Cambridge University
2015 - Present
Affiliated Professor of Clincial Neuroscience, Copenhagen
2013 - Present
Cambridge University Hospitals NHS Trust Dementia Lead
2010 - 2015
Reader in Cognitive Neurology, University of Cambridge
2009 - 2021
Wellcome Trust Senior Research Fellow in Clinical Science
2009 - Present
Program Leader, MRC Cognition and Brain Sciences Unit
2005 - Present
Consultant Neurologist, Addenbrooke's Hospital, Cambridge
2005 - 2009
Wellcome Trust Clinical Research Fellow
2004 - 2005
DRCMR Postdoc and Reservelæge, Rigshospitalet
Publications
Selected Publications:
Hughes LE, Rittman T, Robbins TW, Rowe JB. (2018). "Reorganization of cortical oscillatory dynamics underlying disinhibition in frontotemporal dementia." Brain. 141(8):2486-2499. doi: 10.1093/brain/awy176.
Cope TE, Rittman T, …., O'Brien JT, Rowe JB. (2018). "Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy." Brain 141(2): 550-567.
Sami S, Williams N, …., Rowe JB. (2018). "Neurophysiological signatures of Alzheimer's disease and frontotemporal lobar degeneration: pathology versus phenotype." Brain 141(8): 2500-2510.
Passamonti L, Vázquez Rodríguez P, …., O'Brien JT, Rowe JB. (2017). "18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy." Brain 140(3): 781-791.
Hughes LE, Rittman T, Regenthal R, Robbins TW, Rowe JB. (2015). "Improving response inhibition systems in frontotemporal dementia with citalopram." Brain 138(Pt 7): 1961-1975.
For the complete list, go to: https://scholar.google.com/citations?user=2_i6GTYAAAAJ&hl=en